Ledger.Open graph →
SEC Form D · filed October 10, 2023

Avalyn Pharma Inc

Offering
$189.2M
Sold
$189.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Ketan W. Patel · Seattle, WADirectorTiba W. Aynechi · Seattle, WADirectorNiall W. O'Donnell · Seattle, WADirectorJohn Ajay · Palm Beach Gardens, FLDirectorRandall R. Kendrick · Dallas, TXDirectorCary Marr · GEORGE TOWN, GRAND CAYMAN, Cayman IslandsDirectorLyn Baranowski · Seattle, WAExec · DirectorPeter Moldt · San Mateo, CADirectorCassandra G. Luca · Seattle, WADirectorJonathan Leff · South San Francisco, CADirectorJill G. Carroll · Seattle, WADirectorGeoffrey Kowalski · Laguna Niguel, CADirectorBenjamin Swinford · Costa Mesa, CADirectorMichael Garland · Nashville, TNDirectorLyn Baranowski · Seattle, WAExec · DirectorPeter Moldt · San Carlos, CADirectorCassandra G. Luca · Seattle, WADirectorJonathan Leff · San Francisco, CADirectorJill G. Carroll · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗